BBIO (BridgeBio Pharma, Inc. Common Stock) Stock Analysis - Politician Trades
BridgeBio Pharma, Inc. Common Stock (BBIO) is a publicly traded Healthcare sector company. As of May 21, 2026, BBIO trades at $67.69 with a market cap of $12.79B and a P/E ratio of -18.26. BBIO moved +3.41% today. Year to date, BBIO is -7.08%; over the trailing twelve months it is +102.37%. Its 52-week range spans $21.72 to $84.94. Analyst consensus is strong buy with an average price target of $109.00. Rallies surfaces BBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded BBIO stock?
Recent politician trading activity in BBIO includes disclosures from Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
BBIO Key Metrics
Key financial metrics for BBIO
Metric
Value
Price
$67.69
Market Cap
$12.79B
P/E Ratio
-18.26
EPS
$-3.73
Dividend Yield
0.00%
52-Week High
$84.94
52-Week Low
$21.72
Volume
2.32M
Avg Volume
0
Revenue (TTM)
$579.96M
Net Income
$-729.88M
Gross Margin
95.13%
Congressional Trades in BBIO
Gilbert Cisneros purchase BBIO on Sep 22, 2025 (amount: $15.00K).
Recent politician trading activity in BBIO includes disclosures from Gilbert Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in BBIO?
Yes. Rallies tracks politician and congressional stock disclosures for BBIO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBIO. It does not provide personalized investment advice.
